Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin

Journal of Investigative Dermatology

Volumn 125, Issue 3, 2005, Pages 491-498

  Komine, Mayumi ^a   Kakinuma, Takashi ^a   Kagami, Shinji ^a   Hanakawa, Yasushi ^b   Hashimoto, Koji ^b   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

CCL17; HaCaT; NF B; P38; Roxithromycin (RXM); Thymus and activation regulated chemokine (TARC)

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BAY 11 7805; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PARTHENOLIDE; ROXITHROMYCIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4 ((3 BROMOPHENYL)AMINO) 6,7 DIMETHOXYQUINAZOLINE; 4-((3-BROMOPHENYL)AMINO)-6,7-DIMETHOXYQUINAZOLINE; ANTIINFECTIVE AGENT; BAY 11 7085; BAY 11-7085; BETA CHEMOKINE; CCL17 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRILE; QUINAZOLINE DERIVATIVE; SESQUITERPENE; SULFONE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG PROTEIN BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INHIBITION KINETICS; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; SIGNAL TRANSDUCTION;

ANTI-BACTERIAL AGENTS; CELLS, CULTURED; CHEMOKINES, CC; HUMANS; INTERFERON TYPE II; KERATINOCYTES; NF-KAPPA B; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; ROXITHROMYCIN; SESQUITERPENES; SIGNAL TRANSDUCTION; SULFONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27144538707     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23840.x     Document Type: Article

References (53)

1. Abeyama K, Kawahara K, Iino S, et al: Antibiotic cyclic AMP signaling by "primed" leukocytes confers anti-inflammatory cytoprotection. J Leukoc Biol 74:908-915, 2003
2. Banno T, Adachi M, Mukkamala L, Blumenberg M: Unique keratinocyte- specific effects of interferon-gamma that protect skin from viruses, identified using transcriptional profiling. Antivir Ther 8:541-554, 2003
3. Banno T, Gazel A, Blumenberg M: Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 279:32633-32642, 2004
4. Berin MC, Eckmann L, Broide DH, Kagnoff MF: Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 24:382-389, 2001
5. Bernardini G, Hedrick J, Sozzani S, et al: Identification of the CC chemokine TARC and macrophage inflammatory protein-1b as novel functional ligands for the CCR8 receptor. Eur J Immunol 28:582-588, 1998
6. Bryskier A: Roxithromycin: Review of its antimicrobial activity. J Antimicrob Chemother 41 (Suppl. B):1-21, 1998
7. Campbell JJ, Haraldsen G, Pan J, et al: The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400:776-780, 1999
8. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ: Abnormal NF-kappaB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes. J Dermatol Sci 26:67-78, 2001
9. Chen Q, Koga T, Uchi H, et al: Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes. J Dermatol Sci 29:97-103, 2002
10. Cui CH, Honda K, Saito N, et al: Effect of roxithromycin on eotaxin-primed reactive oxygen species from eosinophils. Int Arch Allergy Immunol 125 (Suppl. 1):38-41, 2001
11. Donato NJ, Gallick GE, Steck PA, Rpsenblum MG: Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity. J Biol Chem 264:20474-20481, 1989
12. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB: Tumor necrosis factor alpha activates human immunodeficiency viorus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 86:5974-5978, 1989
13. Fujii-Maeda S, Kajiwara K, Ikizawa K, et al: Reciprocal regulation of thymus and activation-regulated chemokine/macrophage-derived chemokine production by interleukin (IL)-4/IL-13 and interferon-gamma in HaCaT keratinocytes is mediated by alternations in E-cadherin distribution. J Invest Dermatol 122:20-28, 2004
14. Fujita K, Shimizu T, Majima Y, Sakakura Y: Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells. Eur Arch Otorhinolaryngol 257:199-204, 2000
15. Fumimori T, Honda S, Migita K, et al: Erythromycin suppresses the expression of cycloxygenase-2 in rheumatoid synovial cells. J Rheumatol 31:436-441, 2004
16. Genin P, Algarte M, Roof P, Lin R, Hiscott J: Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol 164:5352-5361, 2000
17. Gil MP, Bohn E, O'Guin AK, et al: Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 98:6680-6685, 2001
18. Goh KC, Haque SJ, Williams BR: p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 118:5601-5608, 1999
19. Hanakawa Y, Amagai M, Shirakata Y, Sayama K, Hashimoto K: Different effects of dominant negative mutants of desmocollin and desmoglein on the cell-cell adhesion of keratinocytes. J Cell Sci 113:1803-1811, 2000
20. Hiroi M, Ohmori Y: The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-kappa B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-gamma gene. J Biol Chem 278:651-660, 2003
21. Holvoet S, Vincent C, Schmitt D, Serres M: The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Exp Cell Res 290:108-119, 2003
22. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O: Molecular cloning of a novel T cell-derived CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 271:21514-21521, 1996
23. Kakinuma T, Nakamura K, Wakugawa M, et al: Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107:535-541, 2001
24. Kakinuma T, Sugaya M, Nakamura K, Kaneko F, Wakugawa M, Matsushima K, Tamaki K: Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48:23-30, 2003
25. Kaneko Y, Yanagihara K, Seki M, et al: Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Physiol Lung Cell Mol Physiol 285:L847-L853, 2003
26. Kippenberger S, Loitsch S, Guschel M, Muller J, Kaufmann R, Bernd A: Hypotonic stress induces E-cadherin expression in cultured human keratin-ocytes. FEBS Lett 579:207-214, 2005
27. Komine M, Tamaki K: An open trial of oral macrolide treatment for psoriasis vulgaris. J Dermatol 27:508-512, 2000
28. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M: Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157:1829-1832, 1998
29. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LJ, Kimura H, Sugiyama Y: Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Nippon Kyobu Shikkan Gakkai Zasshi 25:632-642, 1987
30. Kyriaskis JM, Banerjee P, Nikolakaki E, Rubie EA, Ahmad MR Avruch J, Woodgett JR: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160, 1994
31. Laprise P, Chailler P, Houde M, Beaulieu JF, Boucher MJ, Rivard N: Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MARK activation. J Biol Chem 277:8226-8234, 2002
32. Mascia F, Mariani V, Girolomoni G, Pastore S: Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 163:303-312, 2003
33. Matsuyama T, Hidaka K, Furuno T, Hara N: Neutrophil-induced endothelial cell damage: Inhibition by a 14-membered ring macrolide through the action of nitric oxide. Int Arch Allergy Immunol 114:111-115, 1997
34. Nakajima K, Yomanaka Y, Nakae K, et al: A central role for Stat-3 in IL-6-induced regulation of growth and differentiation in M1 kukemia cells. EMBO J 15:3651-3658, 1996
35. Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, Yoshie O: Selective induction of Th2-attracting chemokine CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 78:1665-1674, 2004
36. Nguyen VAT, Chen J, Hong F, Ishac EJN, Gao B: Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT signaling pathways in hepatocytes: Differential regulation by acute ethanol via protein kinase C-dependent mechanism. Biochem J 349:427-434, 2000
37. Noma T, Aoki K, Hayashi M, Yoshizawa I, Kawano Y: Effect of roxithromycin on T lymphocyte proliferation and cytokine production elicited by mite antigen. Int Immunopharmacol 1:201-210, 2001
38. Noma T, Ogawa N: Roxithromycin enhances lymphocyte apoptosis in Dermatophagoides-sensitive childhood asthma. J Allergy Clin Immunol 111:646-647, 2003
39. Oishi K, Sonoda F, Kobayashi S, Iwagaki A, Nagatake T, Matsushima K, Matsumoto K: Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway disease. Infect Immunity 62:4145-4152, 1994
40. Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, Stark GR: Stat1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 98:6674-6679, 2001
41. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC: CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 194:1541-1547, 2001
42. Robinson CM, Shirey KA, Carlin JM: Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha. J Interferon Cytokine Res 223:413-421, 2003
43. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875-883, 1998
44. Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ: Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol 289:459-471, 1999
45. Scaglione F, Rossoni G: Comparative anti-inflammatory effects of roxithromycin, azithromycin and Clarithromycin. J Antimicrob Chemother 41 (Suppl. B): 47-50, 1998
46. Shoji T, Yoshida S, Sakamoto H, Hasegawa H, Nakagawa H, Amayasu H: Antiinflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. Clin Exp Allergy 29:950-956, 1999
47. Sugiyama Y, Yanagisawa K, Tominaga SI, Kitamura S: Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. Eur Respir J 14:1113-1116, 1999
48. Takizawa H, Desaki M, Ohtoshi T, et al: Erythromycin suppresses interleukin-6 expression by human bronchial epithelial cells; a potential mechanism of its actiinflammatory action. Biochem Biophys Res Commun 210:781-786, 1995
49. Takizawa H, Desaki M, Ohtoshi T, et al: Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 156:266-271, 1997
50. Tomic-Canic M, Komine M, Freedberg IM, Blumenberg M: Epidermal signal transduction and transcription factor activation in activated keratin-ocytes. J Dermatol Sci 17:167-181, 1998
51. Tsuda T, Tohyama M, Yamasaki K, et al: Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 31:37-42, 2004
52. Yazawa N, Ihn H, Yamane K, Etoh T, Tamaki K: The successful treatment of prurigo pigmentosa with macrolide antibiotics. Dermatol 202:67-69, 2001
53. Zlotnik A, Yoshie O: Chemokines: A new classification system and their role in immunity. Immunity 12:121-127, 2000